174 related articles for article (PubMed ID: 20538522)
1. Collaborative actions in anti-trypanosomatid chemotherapy with partners from disease endemic areas.
Dujardin JC; González-Pacanowska D; Croft SL; Olesen OF; Späth GF
Trends Parasitol; 2010 Aug; 26(8):395-403. PubMed ID: 20538522
[TBL] [Abstract][Full Text] [Related]
2. Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
Espuelas S; Plano D; Nguewa P; Font M; Palop JA; Irache JM; Sanmartín C
Curr Med Chem; 2012; 19(25):4259-88. PubMed ID: 22834813
[TBL] [Abstract][Full Text] [Related]
3. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
González M; Cerecetto H
Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
[TBL] [Abstract][Full Text] [Related]
4. Leishmaniasis and poverty.
Alvar J; Yactayo S; Bern C
Trends Parasitol; 2006 Dec; 22(12):552-7. PubMed ID: 17023215
[TBL] [Abstract][Full Text] [Related]
5. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
[TBL] [Abstract][Full Text] [Related]
6. Developments in the treatment of visceral leishmaniasis.
den Boer ML; Alvar J; Davidson RN; Ritmeijer K; Balasegaram M
Expert Opin Emerg Drugs; 2009 Sep; 14(3):395-410. PubMed ID: 19708817
[TBL] [Abstract][Full Text] [Related]
7. Boron-based drugs as antiprotozoals.
Jacobs RT; Plattner JJ; Keenan M
Curr Opin Infect Dis; 2011 Dec; 24(6):586-92. PubMed ID: 22001943
[TBL] [Abstract][Full Text] [Related]
8. Antiprotozoal compounds: state of the art and new developments.
Astelbauer F; Walochnik J
Int J Antimicrob Agents; 2011 Aug; 38(2):118-24. PubMed ID: 21549569
[TBL] [Abstract][Full Text] [Related]
9. Trypanosomes at the gates.
Cross GA
Science; 2005 Jul; 309(5733):355. PubMed ID: 16020696
[No Abstract] [Full Text] [Related]
10. Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.
Urbina JA
Acta Trop; 2010; 115(1-2):55-68. PubMed ID: 19900395
[TBL] [Abstract][Full Text] [Related]
11. Management of trypanosomiasis and leishmaniasis.
Barrett MP; Croft SL
Br Med Bull; 2012; 104(1):175-96. PubMed ID: 23137768
[TBL] [Abstract][Full Text] [Related]
12. To fully tackle the gang of four, needs-driven R & D is essential.
Torreele E; Royce C; Don R; Sevcsik AM; Croft S
PLoS Med; 2006 Jun; 3(6):e282; author reply e284. PubMed ID: 16789804
[No Abstract] [Full Text] [Related]
13. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
World Health Organization
World Health Organ Tech Rep Ser; 2012; (975):v-xii, 1-100. PubMed ID: 23484340
[TBL] [Abstract][Full Text] [Related]
14. Parasitology. Drugs to combat tropical protozoan parasites.
Gelb MH; Hol WG
Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
[No Abstract] [Full Text] [Related]
15. [Trypanosomiases].
Pelloux H; Aznar C; Bouteille B
Rev Prat; 2006 Dec; 56(20):2209-16. PubMed ID: 17352316
[TBL] [Abstract][Full Text] [Related]
16. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
[TBL] [Abstract][Full Text] [Related]
18. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
Chappuis F; Sundar S; Hailu A; Ghalib H; Rijal S; Peeling RW; Alvar J; Boelaert M
Nat Rev Microbiol; 2007 Nov; 5(11):873-82. PubMed ID: 17938629
[TBL] [Abstract][Full Text] [Related]
19. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
[TBL] [Abstract][Full Text] [Related]
20. Research needs for Chagas disease prevention.
Abad-Franch F; Santos WS; Schofield CJ
Acta Trop; 2010; 115(1-2):44-54. PubMed ID: 20227378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]